Study of IMC-S118AI for Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new drug called IMC-S118AI in people with type 1 diabetes. The goal is to see if it can help preserve the remaining function of insulin-making cells in the pancreas, which are important for controlling blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes (not type 2 or other forms).
- Your body mass index (BMI) is between 18 and 25.
- You have a specific genetic marker called HLA-A*02:01.
- Your pancreas still produces some insulin (remaining beta-cell function).
- You have not taken immune-modulating drugs for diabetes before.
- You do not have a history of heart disease, cancer, or repeated low blood sugar due to not following insulin plans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests a new drug called SAB-142, which aims to stop the immune system from attacking insulin-making cells in type 1 diabetes. It may help preserve your body's ability to make insulin. The trial will check if the drug is safe and effective.
This study tests a new treatment called GNTI-122 for adults recently diagnosed with type 1 diabetes who still make some insulin. It aims to see if the treatment can help protect the cells that produce insulin.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.